Opinion|Videos|July 30, 2024
Pharmacists Enhancing RSV Care
Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, provides key takeaways and advice to pharmacists on the administration of RSV vaccines.
Advertisement
Episodes in this series
Video content above is prompted by the following question:
- What additional information on this subject do you feel your peers or colleagues would benefit from knowing?
Advertisement
Related to this article
RSV hospitalization raised short-term invasive pneumococcal disease risk, especially among unvaccinated individuals.
CDC surveillance data show that approximately 10% of adults hospitalized with RSV died during hospitalization or within 60 days of discharge.
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Drives First-Line Immunotherapy Selection in NSCLC? Data, Payers, and Habit
2
FDA Grants Priority Review to Zanubrutinib Plus Rituximab for Previously Untreated MCL
3
AHA 2026: Insights on Oral PCSK9, Survodutide, and HF Care Come to Chicago
4
October Neurology News: Huntington Disease Gene Therapy, Remibrutinib in MS, and AI Medical Advice
5